Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care

O. Savran (Hvidovre, Denmark), N. Godtfredsen (Hvidovre, Denmark), T. Sørensen (Værløse, Denmark), C. Jensen (Præstø, Denmark), C. Suppli Ulrik (Hvidovre, Denmark)

Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session: Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session type: Poster Discussion
Number: 5006
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Savran (Hvidovre, Denmark), N. Godtfredsen (Hvidovre, Denmark), T. Sørensen (Værløse, Denmark), C. Jensen (Præstø, Denmark), C. Suppli Ulrik (Hvidovre, Denmark). Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care. 5006

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characteristics of COPD patients treated with inhaled corticosteroid in primary care
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011


Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005

Inhaled corticosteroid therapy on admission of hospitalized patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 243s
Year: 2002

Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010


Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008


Adherence of stable COPD patients to inhaled pharmacotherapy
Source: Annual Congress 2011 - COPD management
Year: 2011


Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010